Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dipak Patil
Institution:
Sun Pharma (India)
Observed institution:
Sun Pharma (India)
ORCID:
0009-0008-8690-3302
Observed ORCID:
0009-0008-8690-3302
OpenAlex ID:
A5127746517
Semaglutide Injection in Indian Patients With Type 2 Diabetes Mellitus: A Randomised, Phase III , Active‐Controlled Study
2026
·
Unnikrishnan Ambika Gopalakrishnan
, Ameya Sudhakar Joshi
, et al.
·
Diabetes Obesity and Metabolism
·
3
Sitagliptin, Metformin and Glimepiride Fixed‐Dose Combination Compared to Co‐Administration of Metformin and High‐Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Double‐Dummy, Phase 3 Clinical Study
2026
·
Rakesh Sahay
, Ambanna Gowda
, et al.
·
Diabetes Obesity and Metabolism
·
2
Clinical Outcomes with High-Dose Amoxycillin–Clavulanate Suspension in Children with Respiratory Tract Infections: A Prospective, Multicentre, Phase IV Study in India
2026
·
Rajib Ray
, Ashil Dilipbhai Manavadaria
, et al.
·
Advances in Therapy
·
1
PDF
Semaglutide Injection Once‐Weekly for Weight Management in Adults: Results From A Randomized Phase III , Active‐Controlled Study
2026
·
Unnikrishnan Ambika Gopalakrishnan
, Ameya Joshi
, et al.
·
Diabetes Obesity and Metabolism
·
1
A fixed dose combination of tamsulosin and tadalafil in men with benign prostatic hyperplasia and erectile dysfunction: a prospective, multicenter, phase IV study
2026
·
Chirag Gupta
, Avinash T. S.
, et al.
·
World Journal of Urology
·
1
PDF
Efficacy and Safety of Dapagliflozin, Glimepiride, and Metformin Fixed-Dose Combination Tablet in Type 2 Diabetes: A Phase III Trial
2026
·
Prakash Kurmi
, Manish Kumar Singh
, et al.
·
Advances in Therapy
PDF
Late Breaking Abstract - A Phase III, Randomized, Multicentre, Active controlled study to evaluate Fluticasone Furoate, Umeclidinium and Vilanterol in Uncontrolled Asthma Management
2026
·
Dipesh Sonawane
, Piyush Arora
, et al.
·
European Respiratory Journal
EP640 - ECE_3474 - Correlation of weight loss and SF-36 physical function score in weight management with semaglutide injection: post-hoc analysis of phase 3 Study
2026
·
Unnikrishnan Gopalkrishnan
, Ameya Joshi
, et al.
·
European Journal of Endocrinology
PDF
EP403 - ECE_3269 - Efficacy and safety of semaglutide injection in weight management: a subgroup analysis in patients based on Waist circumference
2026
·
Unnikrishnan Gopalkrishnan
, Ameya Joshi
, et al.
·
European Journal of Endocrinology
PDF
EP565 - ECE_3436 - Correlation between weight loss and reduction in waist circumference in weight management with semaglutide injection: post-hoc analysis of phase 3 study
2026
·
Unnikrishnan Gopalkrishnan
, Ameya Joshi
, et al.
·
European Journal of Endocrinology
EP509 - ECE_3401 - Effect of semaglutide injection in physical function: a post-hoc analysis of a phase III study of in weight management
2026
·
Unnikrishnan Gopalkrishnan
, Ameya Joshi
, et al.
·
European Journal of Endocrinology
PDF
EP596 - ECE_2764 - A subgroup analysis of phase 3 study of semaglutide injection in type 2 diabetes mellitus patients aged <40 years, 40 to <50 years and ≥50 years
2026
·
Dipesh Sonawane
, Unnikrishnan Gopalkrishnan
, et al.
·
European Journal of Endocrinology
PDF
EP689 - ECE_2790 - Efficacy and Safety of Semaglutide Injection in Weight management: A subgroup analysis of patients based on BMI
2026
·
Unnikrishnan Gopalkrishnanl
, Ameya Joshi
, et al.
·
European Journal of Endocrinology
PDF
EP788 - ECE_3157 - Efficacy and safety of semaglutide injection in type 2 diabetes mellitus: a subgroup analysis of patients with mild renal impairment
2026
·
Dipesh Sonawane
, Unnikrishnan Gopalkrishnan
, et al.
·
European Journal of Endocrinology
PDF
EP639 - ECE_3171 - Efficacy and safety of semaglutide injection in weight management: a subgroup analysis in mild renal impairment patients
2026
·
Unnikrishnan Gopalkrishnan
, Ameya Joshi
, et al.
·
European Journal of Endocrinology
PDF
EP636 - ECE_3154 - A subgroup analysis of Phase 3 study of Semaglutide Injection in Type 2 Diabetes Mellitus patients based on BMI: <23 kg/m2, 23 to <25 kg/m2 and ≥25 kg/m2
2026
·
Dipesh Sonawane
, Unnikrishnan Gopalkrishnan
, et al.
·
European Journal of Endocrinology
PDF
Clinical outcomes with a fixed-dose combination of oral montelukast and acebrophylline in bronchial asthma: a prospective, single-arm clinical study
2026
·
Rakhi Ludam
, Mayank Agrawal
, et al.
·
Journal of Asthma
PDF
Clinical outcomes with a fixed-dose combination of oral Montelukast and Acebrophylline in bronchial asthma: a prospective, single-arm clinical study
2026
·
Rakhi Ludam
, Mayank Agrawal
, et al.
·
Figshare
Author response for "Semaglutide Injection Once-Weekly for Weight Management in Adults: Results from A Randomized Phase III, Active-controlled Study"
2026
·
Unnikrishnan Ambika Gopalakrishnan
, Ameya Joshi
, et al.
·
Publons reviews and discussion
Author response for "Semaglutide Injection Once-Weekly for Weight Management in Adults: Results from A Randomized Phase III, Active-controlled Study"
2026
·
Unnikrishnan Ambika Gopalakrishnan
, Ameya Joshi
, et al.
·
Publons reviews and discussion
Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate‐to‐Severe Endometriosis Pain: A Phase III , Multicentric, Double‐Blind, Active‐Controlled, Non‐Inferiority Study
2026
·
Sneha Bhoir
, Jaldhara Patel
, et al.
·
BJOG An International Journal of Obstetrics & Gynaecology
Author response for "Semaglutide Injection in Indian Patients with Type 2 Diabetes Mellitus: A Randomized, Phase III, Active-controlled Study"
2026
·
Unnikrishnan Ambika Gopalakrishnan
, Ameya Sudhakar Joshi
, et al.
·
Publons reviews and discussion
Author response for "Sitagliptin, metformin, and glimepiride fixed dose combination compared to co-administration of metformin and high-dose glimepiride in Indian patients with type 2 diabetes: A randomised, double-blind, double-dummy, phase 3 clinical study"
2026
·
Rakesh Sahay
, Ambanna Gowda
, et al.
·
Publons reviews and discussion
Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active‐Controlled Study
2026
·
Brij Mohan
, S. Vasanth Kumar
, et al.
·
Journal of Diabetes
Show more works
View as search
Works count:
24
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type